Radiation-Oncology Center Change Location
Welcome to the Edward C. Loughlin Radiation-Oncology Center
Radiation therapy uses high-energy x-rays to fight cancer cells. Grady’s Edward C. Loughlin, Jr. Radiation Oncology Center is a leader in the use of an advanced radiation technique known as Intensity Modulated Radiation Therapy (IMRT). IMRT allows Grady doctors to precisely control the intensity of radiation a tumor receives. Radiation oncologists also use image guidance to precisely target a tumor. Radiation may be given externally or through small radioactive pellets that are precisely placed in the body (brachytherapy). Brachytherapy delivers a higher dose of radiation over a shorter period. It has been effective in treating prostate, cervical, uterine, vaginal, head, neck, and breast cancers.
Keeping Care Safe
ALL patients and visitors must wear a mask covering their mouth and nose, regardless of vaccination status.
Every hospital treats patients. At Grady, we strive to treat them better, more efficiently, and more effectively. Our mission to care for all who need us attracts physicians from across the nation. They are drawn here by the knowledge that we test the limits of medicine by innovating existing standards of care, researching cutting-edge drugs and therapies, and exploring novel treatments.
Our zeal for innovation has given Grady a national reputation for medical advancement in areas like cancer, burn, stroke, diabetes, infectious diseases, women’s health, sickle cell, and other conditions cared for by specialists in our centers of excellence. Access to all of these accredited practices is available to every Grady patient and our collegial environment means that specialists routinely help to care for their colleagues’ patients.
Though clinicians are drawn by Grady’s reputation, most are employed by the Emory and Morehouse schools of medicine, which staff our medical services. Grady is one of a handful of U.S. health systems whose patients are cared for by faculty members of two medical schools. This reinforces our commitment to ongoing innovation.